Presence and Propensities of Cutaneous Immunofluorescence in <scp>ANCA</scp> ‐Associated Vasculitis
The authors declare no conflicts of interest. Dr. Flowers has served as a principal investigator for Abbvie, Acelyrin, Clinuvel, Regeneron/Sanofi, and Sun Pharmaceuticals. He has served on advisory boards for Argenx, Bristol-Myers Squibb, and Janssen. Dr. Derebail has served as a consultant for Amgen, Bayer, Merck, Forma Therapeutics, and Novartis and has received honoraria from UpToDate. Data available on request.
Authors
- Richard Flowers (ORCID: https://orcid.org/0000-0003-4618-9630)
- Galen Foulke (ORCID: https://orcid.org/0000-0002-4390-5200)
- Julian Stashower (ORCID: https://orcid.org/0000-0001-5520-413X)
- Nakisa B. Sadeghi (ORCID: https://orcid.org/0000-0002-0227-7498)
- Sarah E. Gradecki (ORCID: https://orcid.org/0000-0002-7574-9011)
- Matthew F. Helm (ORCID: https://orcid.org/0000-0001-7469-8569)
- Briana Heinly
- Vimal K. Derebail (ORCID: https://orcid.org/0000-0002-7662-7497)
- Karlyn Pollack (ORCID: https://orcid.org/0000-0002-5531-5080)
- Ugochukwu Kingsley Odega
Institutions
- University of North Carolina at Chapel Hill (US)
- West Virginia University (US)
- Pennsylvania State University (US)
- University of Virginia (US)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1111/cup.14787
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases